Clinical Performance of a Chlorhexidine Antimicrobial Dressing
- Conditions
- Catheterization
- Interventions
- Drug: Transparent Adhesive Dressing
- Registration Number
- NCT00516906
- Lead Sponsor
- Solventum US LLC
- Brief Summary
Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV Dressing
- Detailed Description
Prospective, controlled, randomized, clinical trial comparing the 3M™ TegadermTM CHG (Chlorhexidine Gluconate) IV Securement Dressing (3M Healthcare, St Paul, MN) to a standard transparent dressing.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 68
- Males or Females over 18 years of age
- Patients with an existing, or newly inserted, central venous catheter
- Patients who require the catheter for at least 3 days
- Sensitivity to chlorhexidine
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Transparent Adhesive Dressing Transparent Adhesive Dressing Standard of Care Non-Antimicrobial Transparent Adhesive Dressing CHG antimicrobial transparent dressing Chlorhexidine gluconate Chlorhexidine gluconate antimicrobial transparent adhesive dressing
- Primary Outcome Measures
Name Time Method Clinician Overall Satisfaction With Catheter Securement Daily up to 7 Days (average 3-7 days of wear) Clinician Overall Satisfaction with Catheter Securement Five Point Scale: 1 = Very Good, 5= Very Poor
- Secondary Outcome Measures
Name Time Method Clinician Overall Satisfaction With Dressing Daily up to 7 Days (average 3-7 days of wear) Clinician Overall Satisfaction with Dressing Five point scale: 1= Very Good, 5= Very poor
Rating of Skin Condition Daily up to 7 Days (average 3-7 days of wear) Ratings of skin condition for erythema on a 0 to 3 scale (0 = None, 1=Mild, 2=Moderate, 3=Severe)